$ISIG Why I believe ISIG could squeeze to $100 per share. MULTIDAY RUNNER. 61% shorted, 210.40 percent CTB from Shortsqueeze
MyMD Pharmaceuticals Announces Publication Of Phase 1 Data For Oral TNF-alpha Inhibitor MYMD-1 In Peer-Reviewed Journal Drug Research
MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and
